Literature DB >> 26040030

The expression of CCN2, IQSEC, RSPO1, DNAJC15, RIPK2, IL13RA2, IRS1, and IRS2 genes in blood of obese boys with insulin resistance.

D O Minchenko, V V Davydov, O A Budreiko, O S Moliavko, D K Kulieshova, O V Tiazhka, O H Minchenko.   

Abstract

The development of obesity and its metabolic complications is associated with dysregulation of various intrinsic mechanisms, which control basic metabolic processes via changes in the expression of numerous regulatory genes. We studied the expression of the subset of genes, which responsible for control of cell growth and glucose metabolism, in blood cells of obese boys with normal and impaired insulin sensitivity as well as in normal (control) individuals. It was shown that obesity with normal insulin sensitivity enhances the expression of IRS1, RIPK2, IL13RA2, RSPO1, IQSEC, and CCN2 genes but decreases the expression level IRS2 and DNAJC15 genes in the blood cells as compared to control group. Insulin resistance in obese boys leads to up-regulation of IRS2, RSPO1, and DNAJC15 gene expressions as wells to down-regulation of IRS1 and RIPK2 genes in the blood cells versus obese patients with normal insulin sensitivity. Results of this study provide evidence that obesity affects the expression of the subset of genes related to cell growth and glucose metabolism in blood cells and that insulin resistance in obesity is associated with changes in the expression level of IRS1, IRS2, RIPK2, RSPO1, and DNA JC15 genes, which contribute to the development of insulin resistance and glucose intolerance and possibly reflect some changes in fat tissue.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26040030     DOI: 10.15407/fz61.01.010

Source DB:  PubMed          Journal:  Fiziol Zh        ISSN: 2522-9028


  2 in total

Review 1.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

2.  Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation.

Authors:  Camilo P Martínez-Reyes; Angélica Y Gómez-Arauz; Israel Torres-Castro; Aarón N Manjarrez-Reyna; León F Palomera; Alfonso Olivos-García; Edith Mendoza-Tenorio; Gabriela A Sánchez-Medina; Sergio Islas-Andrade; Guillermo Melendez-Mier; Galileo Escobedo
Journal:  J Diabetes Res       Date:  2018-02-21       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.